Carcinoma: all 6,715 studies
Page 32 of 68. Open to participants first (1,140), then studies with results posted, then the rest; newest registration first within each.
- Inferior Epigastric Lymph Node in Colorectal CarcinosisCompletedNCT04966715Not applicable
- Stereotactic Body Radiotherapy Based Treatment for Hepatocellular Carcinoma With Extensive Portal Vein Tumor ThrombosisCompletedNCT04966195Not applicable
- Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver CancerWithdrawnNCT04965714Phase 2
- Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After SurgeryCompletedNCT04962958Phase 2
- The Efficacy of Hepatic Arterial Infusion Chemotherapy (HAIC) Combine Lenvatinib and Durvalumab (HILL) in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT04961918Phase 2
- A Prospective Multi-center Study on Using Sonazoid Diagnose Early Stage Endometrial CancerStatus unknownNCT04961775
- Occupational Therapy Fatigue Management-Based Intervention for Metastatic Renal Cell CarcinomaWithdrawnNCT04961320Not applicable
- Pre-operative Neoadjuvant Therapy Combined With Surgery for Treating Stage III Hepatocellular CarcinomaStatus unknownNCT04961138Not applicable
- Glycosylation of Exosomes in Prostate and Urothelial CarcinomaTerminatedNCT04960956
- Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing CombinationCompletedNCT04957160
- Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal CarcinomaStatus unknownNCT04955886Phase 2
- Fusion Imaging Contrast-enhanced Ultrasound LI-RADSStatus unknownNCT04955119Not applicable
- TACE Combined with Sintilimab Plus Bevacizumab Biosimilar in Patients with Advanced Hepatocellular Carcinoma (TASK-02)CompletedNCT04954794Phase 2
- A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for LASCCHNCompletedNCT04949503
- Combination Therapy of HAIC and HLX10 and HLX04 in HCC With Major Portal Vein Tumor ThrombosisStatus unknownNCT04947826Phase 2
- Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in BrazilCompletedNCT04947683
- Adjuvant Therapy With Anlotinib for HCCWithdrawnNCT04947371Phase 2
- SCION: SABR and Checkpoint Inhibition of NSCLCWithdrawnNCT04944173Phase 2
- Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b Treatment in Patients With Advanced-Stage HCCStatus unknownNCT04943679
- Quantifying Systemic Immunosuppression to Personalize Cancer TherapyWithdrawnNCT04941365Not applicable
- Window of Opportunity Study of Preoperative Immunotherapy With Atezolizumab in Local SCCHNCompletedNCT04939480Phase 2
- The Neoadjuvant Treatment of Locally Advanced Thoracic Esophageal Squamous Cell CarcinomaStatus unknownNCT04937673Phase 2
- Laser Treatment of Basal Cell CarcinomaCompletedNCT04936932Not applicable
- A Study of Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Access to Medicines Scheme (EAMS) Program in the United KingdomCompletedNCT04936399
- Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive TreatmentStatus unknownNCT04929535Phase 2
- 68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation TherapyTerminatedNCT04928820Phase 2
- Toripalimab Plus Sorafenib in Patients With Advanced-Stage Hepatocellular CarcinomaStatus unknownNCT04926532Phase 1/2
- Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)CompletedNCT04926376Not applicable
- Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell CarcinomaStatus unknownNCT04922450Phase 2
- Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT04921995Phase 2
- Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCCStatus unknownNCT04920214
- Fluoropyrimidine Tailored-dose Based on Uracil Concentration in Patients Treated for Digestive Carcinomas: Evaluation of Clinical PracticeCompletedNCT04918264
- SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular CarcinomaStatus unknownNCT04913480Phase 2
- Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesActive, not recruitingNCT04913337Phase 1/2
- Study of TACE Combined With Lenvatinib to Prevent Postoperative Recurrence in Patients With MVI Positive HCCStatus unknownNCT04911959Phase 1/2
- The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label StudyStatus unknownNCT04909866Phase 2/3
- Study of Safety and Efficiency of the Use of Neutral Argon Plasma in Cyto-reduction of Miliary Implants in the Peritoneal Surface.CompletedNCT04904042Not applicable
- Feasibility Study of a 4 Stage Bowel Obstruction Cancer DietCompletedNCT04898842Not applicable
- A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal CarcinomaCompletedNCT04895345Phase 2
- Complications of Laparoscopic Hysterectomy and Sentinel Lymph Node Biopsy for Endometrial CarcinomaStatus unknownNCT04894552Not applicable
- A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck CancersWithdrawnNCT04892875Phase 1
- Prospective Translational Study Investigating Predictors of Outcome in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab (I-Rene Trial)Status unknownNCT04891055
- TQB2450 Combined With Anlotinib Hydrochloride in the Perioperative Treatment of Hepatocellular Carcinoma Hydrochloride Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With a High Risk of Recurrence or MetastasisStatus unknownNCT04888546Phase 1/2
- Paclitaxel i.v. Plus Cisplatin i.p for NACT in Patients With Advanced Ovarian CancerStatus unknownNCT04885270Phase 3
- Sintilimab and Nimotuzumab Combined With Chemotherapy for the Treatment of R/M HNSCC.Status unknownNCT04882462Phase 2
- Afatinib Plus Toripalimab in Previously Treated ESCC With EGFR Overexpression or EGFR AmplificationStatus unknownNCT04880811Phase 2
- Effect of the PIPAC on the Survival Rate of Patients With Peritoneal Carcinomatosis of Gastric OriginCompletedNCT04879953
- Preoperative Bintrafusp Alfa in Operable Urothelial Carcinoma of the BladderStatus unknownNCT04878250Phase 2
- Domatinostat in Combination With Avelumab in Patients With Treatment-naïve Metastatic Merkel Cell Carcinoma (MERKLIN 1)WithdrawnNCT04874831Phase 2
- Significance of Immunohistochemical Expression of Survivin in Renal Cell CarcinomaCompletedNCT04873180
- Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II StudyStatus unknownNCT04872582Phase 2
- Safety, Tolerability and Pharmacokinetics of TWP-101 in Patients With Advanced Melanoma and Urothelial CarcinomaStatus unknownNCT04871334Phase 1
- Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck CancerCompletedNCT04870840Phase 1
- Binimetinib and Palbociclib Before Surgery for the Treatment of Operable KRAS-Positive Lung, Colorectal, or Pancreatic CancerWithdrawnNCT04870034Early Phase 1
- An Exploratory Clinical Study of SHR6390 and SHR1020 in the Treatment of Esophageal Squamous Cell Carcinoma After Progression on PD-1 AntibodyStatus unknownNCT04866381Phase 2
- (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLCTerminatedNCT04862780Phase 1
- A Study of Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of ChemoimmunotherapyTerminatedNCT04856176Phase 2
- Radiotherapy Plus Durvalumab in Elderly Esophageal Squamous Cell CarcinomaStatus unknownNCT04851132Not applicable
- Tislelizumab Combined With IMRT Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTTStatus unknownNCT04850157Phase 2
- A Neoadjuvant Hepatocellular Carcinoma Study of Camrelizumab in Combination With Apatinib and OxaliplatinStatus unknownNCT04850040Phase 2
- Indocanine Green as Tracer for Lymph Nodes Dissection in Station 253Status unknownNCT04848311Not applicable
- Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular CarcinomaCompletedNCT04847726Not applicable
- A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCCCompletedNCT04844983Phase 2
- Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell CarcinomaActive, not recruitingNCT04844385Phase 2
- Phase III Study ：SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 NegativeActive, not recruitingNCT04842617Phase 3
- Combination 5-FU / Calcipotriene Cream for SCCIS/SCCStatus unknownNCT04839731Early Phase 1
- BI-754091 and Afatinib for Refractory Esophageal Squamous Cell Carcinoma (BEAR Study)CompletedNCT04839471Phase 2
- Tislelizumab Combined With Lenvatinib for Perioperative Treatment of Resectable Primary Hepatocellular CarcinomaStatus unknownNCT04834986Phase 2
- Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell CancerWithdrawnNCT04834349Phase 2
- Nedaplatin in Treatment for Nasopharyngeal CarcinomaCompletedNCT04834206Phase 2
- 9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland CarcinomaWithdrawnNCT04832438Phase 2
- Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC)WithdrawnNCT04831450Phase 2
- A Study of NG-641 and Pembrolizumab in Squamous Cell Carcinoma of the Head and NeckCompletedNCT04830592Phase 1
- Correlation of Peritoneal Fluid CA-125 Levels With Postoperative Tumor HistologyCompletedNCT04830332Not applicable
- Pasireotide to Reduce Clinically Relevant Digestive Leakage After Complete Cytoreductive Surgery (CRS) Plus Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for Peritoneal CarcinomatosisTerminatedNCT04826432Phase 2
- A Study of Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).Status unknownNCT04826406Phase 2
- Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex SequencingCompletedNCT04823871Not applicable
- Perception of the Doctor/Patient Relationship, Disease and Treatment Among Physicians and Their Patients Treated With Systemic Therapy for Hepatocellular Carcinoma "PERCEPTION1"CompletedNCT04823754
- Transarterial Chemoembolization Plus Hypofractionnated Radiotherapy vs. Surgery in Locally Advanced Hepatocellular Carcinoma: an IPTW ComparisonCompletedNCT04823715
- Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal CarcinomaCompletedNCT04823468Not applicable
- Risk Factors for Mortality in Cases of Obstructed Left Colonic CarcinomaCompletedNCT04823416Not applicable
- Radio/Pathological Evaluation of Tongue Cancer InfiltrationStatus unknownNCT04821128
- Surgical Therapy and Survival in HCC/ C.F. Zhang et al.CompletedNCT04820712
- Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT04815720Phase 1/2
- Outcome of Radiation Therapy in Urinary Bladder Squampus Cell CarcinomaStatus unknownNCT04815629
- A Study to Evaluate the Combination of ATX-101 and Platinum-based ChemotherapyTerminatedNCT04814875Phase 1/2
- Sequential Treatment of Hepatocellular Carcinoma by Transarterial Chemoembolization and Local Ablation or External RadiationCompletedNCT04813861
- Study of Anlotinib Plus Sintilimab in the Treatment of Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT04813406Not applicable
- CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and BloodActive, not recruitingNCT04811846Not applicable
- Early Nutritional Intervention in NPC Patients Undergoing Concurrent ChemoradiotherapyStatus unknownNCT04810936Not applicable
- Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian CancerActive, not recruitingNCT04807166Phase 2
- Carelizumab Combined With Regorafenib in the Treatment of HCC（CARE-2020）Status unknownNCT04806243Phase 2
- Transarterial Embolization Alone Versus Drug-Eluting Beads Chemoembolization for Hepatocellular CarcinomaStatus unknownNCT04803019Phase 3
- Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsActive, not recruitingNCT04802876Phase 2
- Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617Status unknownNCT04801264Early Phase 1
- Study of ONCOFID-P-B™ (PACLITAXEL-HYALURONIC ACID)CompletedNCT04798703Phase 1
- A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal DisseminationStatus unknownNCT04797923Phase 2
- TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Hepatocellular Carcinoma (BCLC-C Stage ): a Prospective Single-arm Phase II Clinical StudyStatus unknownNCT04796025Phase 2
- Observational Study of Correlation Between Recurrent Basal Cell Carcinoma and LocalisationCompletedNCT04795297
- Value of the Laparoscopic Approach in the Surgical Management of Resectable Hepatocellular CarcinomaActive, not recruitingNCT04791735Not applicable